When conjugated with a penetration transporter or a penetrating peptide, these peptides can inhibit proliferation of MLL1-r leukemia cell lines, while showing no apparent toxicity to hematopoietic progenitor cells. The gene discussed is KMT2A; the disease is leukemia.